These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 9679438

  • 1. [Use of anticholinergic antiparkinson agents against adverse drug reactions in a psychiatric department. A quality assurance project].
    Mikkelsen VR.
    Ugeskr Laeger; 1998 Jul 13; 160(29):4323-5. PubMed ID: 9679438
    [No Abstract] [Full Text] [Related]

  • 2. Beneficial effects of combined L-dopa and central anticholinergic in a patient with severe drug-induced parkinsonism and tardive dystonia.
    Looper KJ, Chouinard G.
    Can J Psychiatry; 1998 Aug 13; 43(6):646-7. PubMed ID: 9729698
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [A practical guide for the use of psychopharmacologic agents. II. Antipsychotic and antiparkinson agents].
    Chouinard G.
    Union Med Can; 1976 Sep 13; 105(9):1387-97. PubMed ID: 9720
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Anticholinergic anti-Parkinson agents].
    Taurand S.
    Soins; 1996 Apr 13; (605):61-2. PubMed ID: 8716255
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Excessive antipsychotic dosing in a Canadian outpatient population.
    Barr AM, Panenka WJ, Honer WG, Khara S, Procyshyn RM.
    Psychiatr Serv; 2011 Jun 13; 62(6):682-3. PubMed ID: 21632741
    [No Abstract] [Full Text] [Related]

  • 9. Management of chronic psychotic ambulatory outpatients.
    Petty RG.
    J Clin Psychiatry; 1998 Jun 13; 59 Suppl 19():30-5. PubMed ID: 9847050
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impact of second-generation antipsychotics on the use of antiparkinson agents in nursing homes and assisted-living facilities.
    Touré JT, Brandt NJ, Limcangco MR, Briesacher BA.
    Am J Geriatr Pharmacother; 2006 Mar 13; 4(1):25-35. PubMed ID: 16730618
    [Abstract] [Full Text] [Related]

  • 12. Anticholinergic antiparkinsonian therapy in outpatients treated with neuroleptic drugs: a prescription survey.
    Spila-Alegiani S, Diana G, Menniti-Ippolito F, Raschetti R.
    Eur J Clin Pharmacol; 1995 Mar 13; 48(6):513-7. PubMed ID: 8582472
    [Abstract] [Full Text] [Related]

  • 13. Co-prescription of anticholinergic drugs with neuroleptics.
    Arya DK.
    Br J Hosp Med; 1995 Mar 13; 47(4):304. PubMed ID: 1350493
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Influences of an anticholinergic antiparkinsonian drug, parkinsonism, and psychotic symptoms on cardiac autonomic function in schizophrenia.
    Okada T, Toichi M, Sakihama M.
    J Clin Psychopharmacol; 2003 Oct 13; 23(5):441-7. PubMed ID: 14520119
    [Abstract] [Full Text] [Related]

  • 17. The DEBIT trial: an intervention to reduce antipsychotic polypharmacy prescribing in adult psychiatry wards - a cluster randomized controlled trial.
    Thompson A, Sullivan SA, Barley M, Strange SO, Moore L, Rogers P, Sipos A, Harrison G.
    Psychol Med; 2008 May 13; 38(5):705-15. PubMed ID: 17825122
    [Abstract] [Full Text] [Related]

  • 18. Implementation of a rational pharmacotherapy intervention for inpatients at a psychiatric department.
    Sorensen L, Nielsen B, Stage KB, Brøsen K, Damkier P.
    Nord J Psychiatry; 2008 May 13; 62(3):242-9. PubMed ID: 18622885
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.